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A comparison of HIV outpatient care in primary and secondary 
healthcare-level settings in Zimbabwe
G. McHugh,1 A. Brunskill,2 E. Dauya,1 T. Bandason,1 T. Bwakura,3 C. Duri,4 S. Munyati,1 R. A. Ferrand1,5
As efforts to implement universal testing and treat-ment and achieve UNAIDS 90-90-90 targets (90% 
of people living with HIV [PLHIV] know their diagno-
sis, 90% of these people are accessing treatment and 
90% of those on ART have achieved viral suppression) 
intensify globally, more people than ever are accessing 
antiretroviral therapy (ART). In sub-Saharan Africa in 
2018, where 54% of the world’s people with HIV live, 
an estimated 13.8 million PLHIV were accessing HIV 
treatment and care.1 To ensure ease of access to treat-
ment and remove barriers to care, including shortage 
of healthcare providers, distance to travel to clinics 
and overcrowded facilities, decentralisation of HIV 
services from secondary to primary care-level health 
facilities and task-shifting from physician-led services 
to nurse-led services have been widely implemented 
in many low-income settings.2,3
HIV programmes often focus on HIV viral suppres-
sion following initiation of ART as a marker of success-
ful treatment outcomes.4 However, optimum care 
should include provision for screening and prevention 
of opportunistic infections, comorbidities, as well as 
sexual and reproductive health (SRH) services and psy-
chosocial support.5,6 As people with HIV live longer, 
there is an increasing push towards integrating screen-
ing and management of risk factors for chronic co-
morbidities.6–8 The different health facility tiers may 
vary in their ability to offer services beyond the direct 
treatment and monitoring of HIV treatment. In 2004, 
the Zimbabwean Ministry of Health and Child Care 
(MOHCC) adopted a strategy of decentralising HIV 
care to primary healthcare level.9 Since then, the num-
ber of sites able to provide HIV treatment services and 
ART coverage has increased rapidly and by 2017, there 
were 1566 ART sites (initiating and follow up) and an 
estimated 1 119 909 PLHIV were accessing ART by the 
end of September 2016.10 Recent MOHCC guidance 
recommends that all health care facilities provide ba-
sic prevention, testing and treatment for HIV, inte-
grated with sexual and reproductive health services 
and screening for non-communicable diseases.9
We compared services offered to adult clients at-
tending for HIV care at a physician-led service in a hos-
pital-based outpatient HIV clinic and those offered in a 
nurse-led primary care clinic in Harare, Zimbabwe.
METHODS
Study design and setting
A cross-sectional study was performed at Harare Cen-
tral Hospital (HCH) HIV clinic and the Budiriro Pri-
mary Care clinic (PCC) from June to August 2018. 
HCH is the largest public sector hospital in Harare. Its 
adult HIV outpatient clinic has 3200 registered adult 
clients (aged 18 years). The clinic is staffed by two 
physicians and 18 support staff, consisting of nurses 
and HIV counsellors. ART and cotrimoxazole are pro-
vided free of charge through the national ART pro-
gramme. Attendance to see a nurse or physician is free 
of charge. Budiriro PCC is situated in a high-popula-
tion density suburb in south west Harare, within the 
catchment area of HCH. It is managed by Harare City 
municipal health services. It has 5400 registered cli-
ents with HIV aged 15 years. It has a staff comple-
ment of 12 nurses and HIV counsellors who work on a 
rotational basis, with an average 1–2 nurses staffing 
the HIV care and treatment department daily. A physi-
cian visits weekly to attend to complex clinical cases 
identified by nursing staff. ART and cotrimoxazole are 
provided free of charge at this clinic; however, a user 
fee of US$1.00 is charged each time a client sees a 
nurse, which is required prior to collection of ART 
medication.
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Setting: Decentralisation of HIV care to nurse-led pri-
mary care services is being implemented across low- and 
middle-income countries in sub- Saharan Africa.
Objective: To compare services offered to clients attend-
ing for HIV care at a physician-led and a nurse-led service 
in Harare, Zimbabwe.
Design: A cross-sectional study was performed at Harare 
Central Hospital (HCH) and Budiriro Primary Care Clinic 
(PCC) from June to August 2018. An interviewer-adminis-
tered questionnaire was used to collect sociodemograph-
ics, HIV treatment and clinical history from clients attend-
ing for routine HIV care. The Mann-Whitney U-test was 
used to evaluate for differences between groups for con-
tinuous variables. For categorical variables, the χ2 test 
was used.
Results: The median age of the 404 participants re-
cruited was 38 years (IQR 28–47); 69% were female. Viral 
suppression was comparable between sites (HCH, 70% 
vs. PCC, 80%; P = 0.07); however, screening for comor-
bidities such as cervical cancer screening (HCH, 61% vs. 
PCC, 41%; P = 0.001) and provision of referral services 
(HCH, 23% vs. PCC, 13%; P = 0.01) differed between 
sites.
Conclusion: Efforts to improve service provision in pri-
mary care settings are needed to ensure equity for users 
of health services.
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Inclusion criteria for study participation were age  18 years 
and receiving ART for at least 6 months. Eligible participants were 
consecutively recruited, restricted to 15 a day for logistical ease. 
An interviewer-administered questionnaire was used to collect 
data on sociodemographic characteristics, medical history, in-
cluding ART regimen, health services received at the clinic, un-
derstanding of what viral load and CD4 count results mean, and 
referrals for additional services within the healthcare system, for 
community-based services or both. Laboratory test results were 
obtained from the medical records.
Data were collected on an electronic database on android tab-
lets; statistical analysis was performed using STATA v12 (Stata 
Corp, College Station, TX, USA). The Mann-Whitney U-test was 
used to evaluate for differences between groups for continuous 
variables. For categorical variables, the χ2 test was used.
Ethical considerations
Prior to written informed consent being obtained from partici-
pants, an information sheet, translated into Shona, should the 
participant prefer to read in their vernacular language, was pro-
vided. Questions were answered by research assistants regarding 
study participation. Written informed consent was obtained from 
all participants. Should a participant choose to withdraw from 
the study at any time, they were permitted to do so.
Ethical approval for the study was obtained from the Medical 
Research Council of Zimbabwe (Harare), the Harare City Health 
Department Ethics Committee (Harare), Harare Hospital Ethics 
Committee (Harare), Biomedical Research and Training Institute 
Institutional Review Board (Harare, Zimbabwe) and the London 
School of Hygiene & Tropical Medicine Ethics Committee, Lon-
don, UK.
RESULTS
A total of 404 participants were recruited across both sites. The 
median age was 38 years (interquartile range [IQR] 28–47) and 
69% were female (Table). The median time since HIV diagnosis 
was 7 years (IQR 4–11), and the median duration on ART was 6 
years (IQR 4–10). While participants attending HCH received HIV 
care free of charge, 186 (93%) participants at Budiriro PHC in-
curred a consultation fee at each visit; 14 (7%) clients were ex-
empt from paying a consultation fee as they were older than 65 
years or were employees of Harare City Municipal Service. The 
frequency of clinical review i.e., the consultation with a nurse or 
physician involving symptom review and clinical examination (if 
indicated) prior to routine ART refill differed between settings. 
Furthermore, participants at PCC were required to attend for clin-
ical review on a 3-monthly basis compared to participants at HCH 
(HCH 75% vs. PCC 93%; P  0.001). In addition, those attending 
the PCC had longer waits to see a healthcare provider, with 70% 
at the PCC vs. 15% at the hospital-based clinic having to wait 
longer than 2 hours. (Table).
ART provision and HIV viral load testing
The proportion on second-line regimens (i.e., protease inhibitor 
or integrase inhibitor-based regimens) was higher among partici-
pants attending HCH clinic services (31% vs. 1%; P  0.001), as 
would be expected as patients attending PCCs who are thought to 
be failing treatment or have issues with drug tolerability are re-
ferred to hospital-based clinics for further management.
Drug stock outs in the previous 12 months were rarely re-
ported for both settings, with only one participant reporting a 
stock out of atazanavir/ritonavir at HCH on one occasion and one 
participant in Budiriro PCC reporting a stock out of cotrimoxaz-
ole on one occasion. In total, 361 (89%) participants had an HIV 
viral load performed in the past 12 months: 193 (95%) attendees 
at HCH vs. 168 (84%) attendees at the Budiriro PCC (P  0.001). 
Viral load testing was performed on site (i.e., participants did not 
have to travel to another institution for testing) for 334 of those 
who had an HIV viral load performed. However, 42% of those 
who had had a viral load test in the past 12 months had to return 
on a different day to that of their clinical review for the test to be 
performed, with this occurring more frequently at the PCC (HCH 
37% vs. PCC 48%; P = 0.03). Free viral load testing was provided 
for 359 (99%) participants; of these, 19 paid an additional amount 
for an additional consultation fee at the PCC, as they had to re-
turn on a different day for a test. One participant had a test per-
formed at a private laboratory for US$90.00 and one participant 
had to pay US$5.00. Of the 361 participants who had an HIV viral 
load measurement, 251 (70%) participants received their results 
and 225 (62%) had a record of the result in their patient-held rec-
ords. There was no difference in the proportion who received 
their HIV viral load result by setting (HCH 88% vs. PCC 91%; P = 
0.40). In total, 191 (85%) of those with a viral load result had a 
viral load of 1000 copies/ml, with no difference in the propor-
tion of participants with virological suppression by setting (HCH 
70% vs. PHC 80%; P = 0.07).
Overall, 262 (65%) participants understood that when HIV in-
fection is well controlled, HIV viral load is low, and 292 (72%) 
participants reported that CD4 count should be high. In total, 31 
(8%) participants did not know whether viral load and CD4 mea-
surements should be high or low if HIV viral control was optimal. 
Participants’ understanding of viral load and the relationship of 
CD4 count measurements to HIV infection control did not differ 
between sites.
Only 200 (50%) participants had been referred to a support 
group, with a higher proportion of HCH attendees being referred 
than those attending the Budiriro PCC (55% vs. 43%). Referral for 
additional medical and social services such as food aid, social ser-
vices, mental health services and family planning was generally 
low across both settings (Table).
Ancillary services
Screening for hypertension, chronic kidney disease and cervical 
cancer occurred more frequently at HCH than at Budiriro PCC 
(Table); 162 (42%) participants had a blood pressure measurement 
performed at each clinic visit (HCH 63% vs. PCC 21%; P  
0.0001) and measurement of creatinine, a recommended annual 
test for those taking tenofovir (TDF) containing HIV regimens 
had occurred at least once for 85% of clients at HCH compared to 
98% of clients taking TDF at Budiriro PCC. A higher proportion of 
HCH clinic participants had received isoniazid prophylactic ther-
apy (IPT) for the prevention of tuberculosis (51% vs. 19%; P  
0.001), although only 35% of all participants had ever received 
IPT. The same applied to free condom provision with 75% of HCH 
participants vs. 55% of Budiriro clinic participants receiving con-
doms at clinic visits. The proportion of participants who had chil-
dren living in their households of unknown HIV status was low (n 
= 64, 16%), and overall 70% had been asked to have their chil-
dren tested, with no difference in proportion offered by setting.
DISCUSSION
The process of decentralisation of HIV care has brought the provi-
sion of HIV care closer to clients and communities; task-shifting 
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has helped relieve some of the pressure on heavily burdened ser-
vices in high HIV prevalence settings, as shown by the larger 
number of clients enrolled for HIV care and treatment at Budiriro 
PCC. However, clients continued to spend significant periods of 
time waiting for healthcare consultations in primary care-level 
HIV services. Our findings demonstrate a high level of viral sup-
pression across both sites, supporting the findings of previous 
studies that task shifting of routine HIV care to nurse-led facilities 
does not compromise virological outcomes.11,12 While virological 
outcomes were reassuring, a higher proportion of clients under-
went viral testing in the hospital clinic than at the PCC. The ne-
cessity to return on a different day from the clinical visit for viro-
logical monitoring to be performed may be an explanation for 
this, but this represents a barrier to access of HIV treatment moni-
toring as it requires clients to pay a user fee for an additional visit 
as well as potential loss of earning potential while attending the 
clinic.
The attrition between undergoing the viral test and receiving 
the results is a matter of concern. It is necessary for health care 
providers to communicate client’s virological results in order to 
address issues related to adherence, drug interactions and if neces-
sary, facilitate regimen change to ensure virological suppression 
occurs.4
The focus of HIV management has until recently focused on 
immunological and virological outcomes, but optimum care also 
needs to focus on the psychosocial and sexual health needs of 
people with HIV.5 HIV is associated with an increased risk of in-
fections and other comorbidities such as tuberculosis and cervical 







Primary healthcare clinic 
(n = 200)
n (%) P value
Age, years, median [IQR] 38 [28–47] 33.5 [23–44] 42 [34–49.5] 0.001
Female sex 279 (69) 138 (68) 141 (71) 0.55
Time since HIV diagnosis, years, median [IQR] 7 [4–11] 8 [4–12] 6 [4–10] 0.01
Duration on ART, years, median [IQR] 6 [4–10] 7 [4–11] 6 [3–9] 0.02
ART regimen
 NNRTI* 339 (84) 141 (69) 1981 (99) 0.001
 PI 63 (16) 61 (30) 2 (1) 0.001
 INSTI 1 (1) 1 (1) 0 (0) 0.32
HIV viral load in past 12 months 361 (89) 193 (95) 168 (84) 0.001
Received HIV VL result 251 (70) 135 (70) 116 (69) 40.85
VL  40 copies/ml 168 (75) 83 (70) 85 (80) 0.07
VL  1000 copies/ml 32 (14) 17 (14) 15 (14) 0.97
Time taken to see a provider
 30 min 43 (11) 38 (19) 5 (3) 0.001
 30 min–1 h 101 (25) 83 (41) 18 (9) 0.001
 1–2 h 90 (22) 53 (26) 37 (18) 0.07
 2 h 170 (42) 30 (15) 140 (70) 0.001
Received isoniazid prophylactic therapy 143 (35) 105 (51) 38 (19) 0.001
Renal function testing
 Ever 187 (46) 128 (63) 59 (30) 0.001
 Among those who take tenofovir 167 (89) 109 (85) 58 (98) 0.001
Ever offered cervical screening 142 (51) 84 (61) 58 (41) 0.001
Correct understanding by client about 
association between VL and HIV control
 No 77 (19) 36 (18) 41 (21) 0.47
 Yes 262 (65) 139 (68) 123 (62) 0.16
 Don’t know 65 (16) 29 (14) 36 (18) 0.30
Correct understanding by client about 
association between CD4 and HIV control
 Yes 292 (72) 150 (74) 142 (71) 0.57
 No 69 (17) 30 (15) 39 (20) 0.20
 Don’t know 43 (11) 24 (12) 19 (9) 0.46
Referral to secondary services
 Food aid 72 (18) 46 (23) 26 (13) 0.01
 Community based NGOs 52 (13) 30 (15) 22 (11) 0.27
 Social services 44 (11) 28 (14) 16 (8) 0.06
 Mental health services 18 (4) 13 (6) 5 (3) 0.06
Sexual health
 Offered condoms 262 (65) 153 (75) 109 (54) 0.20
 Offered hormonal contraception 86 (21) 49 (24) 37 (19) 0.18
HIV = human immunodeficiency virus; IQR = interquartile range; ART = antiretroviral therapy; NNRTI = non-nucleoside reverse transcriptase inhibitors; PI = protease inhibitor; 
INSTI = integrase strand transfer inhibitor; VL = viral load; NGO = non-governmental organisation.
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cancer, as well as non-infectious comorbidities such as cardiovas-
cular disease.4,7,13 As populations on ART age, the risk of certain 
comorbidities will also increase, and there is increasing recogni-
tion that comprehensive HIV care will need to include screening 
and management for common comorbidities such as hyperten-
sion and diabetes.14,15 A recent modelling study in Zimbabwe re-
ported that the mean age of PLHIV will increase to 45 years by 
2035, and suggests that at least 26% of PLHIV will have at least 
one non-communicable disease.16 In sub-Saharan Africa, the prev-
alence of chronic kidney disease is estimated to be 13% in the 
general population.17,18 In the case of PLHIV, ART drugs, particu-
larly TDF, is an additional risk factor for development of renal im-
pairment.19 A 3-monthly clinical review allows the opportunity to 
screen for such illnesses; however, in general, those on TDF-con-
taining regimens had previously had at least one measurement of 
their renal function. It is important that such measurements are 
built into an annual health screen so as to become routine and 
not just a one-off, potentially ad-hoc event. There was a signifi-
cant difference between the frequencies of measurement of blood 
pressure at both sites; although clients attending the hospital 
clinic were younger, the proportion of those who had blood pres-
sure measured at each visit was significantly higher than at the 
PCC.
While virological outcomes appeared to be similar by setting 
in our study, those attending the physician-led, hospital-based fa-
cility received more holistic care. Referrals for cervical cancer 
screening was higher in females attending physician-led services 
in the hospital-based clinic than in those attending nurse-led ser-
vices in primary health care; however, overall only 51% of women 
had ever been referred for the service despite visual inspection 
with acetic acid and camera (VIAC) testing being available on site 
at the PCC.
IPT was infrequently offered to clients regardless of setting, de-
spite being recommended in the national guidelines. This may be 
due to drug supply shortage, challenges in excluding active tuber-
culosis or inadequate training of staff. Overall, the provision of 
condoms to clients and family planning was poor in both set-
tings. To note, the proportion of children living in clients house-
holds with unknown HIV status was less than 20% overall, and 
the children of the majority of participants had been offered HIV 
testing.
There are some limitations to this study: it is a cross-sectional 
study comparing only two sites and relies on individual recall and 
client-held records for virological outcomes. However, there were 
equal numbers interviewed at both sites and both sites were 
broadly representative of secondary and primary care level. A 
qualitative component to understand the experiences of clients 
and health providers in both settings may provide additional in-
sights into the challenges that may exist in accessing and provid-
ing services in primary care settings.
The reasons for the differences observed in service provision 
may reflect staffing type and levels, different levels of training, 
higher patient load and different level of resources available to 
providers. While viral suppression outcomes appeared similar, cli-
ents accessing primary care were disadvantaged in terms of access 
to a wider base of screening, referral and preventive services.
In summary, it is necessary to provide equal standards of care 
to clients attending for HIV care and management to ensure equi-
table outcomes, whether care is provided by a physician or a 
nurse. Low-cost screening tests such as blood pressure measure-
ment, mental health screening and cervical cancer screening 
needs to be strengthened in primary care settings. Further studies 
should investigate quality of service provision beyond direct HIV 
treatment outcomes to evaluate the ability of primary care clinics 
to screen and monitor development of non-communicable dis-
eases that can develop as PLHIV grow older. Standardised guide-
lines should be accompanied by monitoring and evaluation, as 
well as adequate support for healthcare providers at primary care 
level to provide optimum care for the increasing numbers of peo-
ple accessing HIV care.
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Contexte  :  La décentralisation de la prise en charge du VIH aux 
services de soins de santé primaires gérés par des infirmiers est en 
voie de mise en œuvre dans des pays à revenu faible ou moyen 
d’Afrique sub-saharienne.
Objectif  :  Comparer les services offerts aux clients consultant pour la 
prise en charge du VIH dans un service géré par un médecin et dans 
un service géré par un infirmier à Harare, Zimbabwe.
Schéma  :  Une étude transversale a été réalisée à l’hôpital central de 
Harare (HCH) et dans les structures de soins de santé primaires (PCC) 
de Budiriro de juin à août 2018. Un questionnaire réalisé lors d’un 
entretien a permis de recueillir des données relatives aux facteurs 
sociodémographiques, au traitement du VIH et aux antécédents des 
clients se présentant pour des soins de routine du VIH. Le test de 
Mann-Whitney a été utilisé pour évaluer les différences entre les 
groupes pour les variables continues. Pour les variables catégoriques, 
on a utilisé le test du χ2.
Résultats  :  Au total, 404 participants ont été recrutés, d’âge médian 
38 ans (IQR 28–47) ; 69% étaient des femmes. La suppression virale a 
été comparable pour les deux sites (HCH, 70% contre PCC, 80% ; P 
= 0,07). Par contre, le dépistage des comorbidités comme celui du 
cancer du col (HCH, 61% contre PCC, 41% ; P = 0,001) et l’offre de 
services de référence (HCH, 23% contre PCC, 13% ; P = 0,01) ont 
différé.
Conclusion  :  Des efforts d’amélioration de la prestation de services 
en soins de santé primaires sont requis pour assurer l’équité aux 
usagers des services de santé.
Marco de referencia: En la actualidad se está implementando la 
descentralización de los servicios relacionados con la infección por el 
VIH hacia servicios de atención primaria a cargo del personal de 
enfermería en los países de ingresos bajos y medianos en África 
subsahariana.
Objetivo: Comparar los servicios que se ofrecen a los usuarios que 
acuden a los servicios relacionados con el VIH dirigidos por personal 
médico o personal de enfermería en Harare, Zimbabwe.
Método: Fue este un estudio transversal realizado en el Hospital 
Central de Harare (HCH) y el consultorio de atención primaria (PCC) 
de Budiriro de junio a agosto del 2018. Mediante un cuestionario 
presentado por un entrevistador, se recogieron datos 
sociodemográficos, información sobre el tratamiento de la infección 
por el VIH y la historia clínica de los usuarios que acudían a la atención 
corriente del VIH. Se evaluaron las diferencias de las variables continuas 
entre los grupos con la prueba de la U de Mann-Whitney. Las variables 
categóricas se evaluaron con la prueba de la χ2.
Resultados: De los 404 participantes inscritos, la mediana de la edad 
fue 38 años (IQR 28-47 años); 69% era de sexo femenino. Los datos 
de supresión viral fueron equivalentes en los diferentes centros (HCH, 
70% contra PCC, 80%; P = 0,07); sin embargo, se observaron 
diferencias con respecto a la detección sistemática de enfermedades 
concomitantes como el cáncer de cuello uterino (HCH, 61% contra 
PCC, 41%; P = 0,001) y la oferta de servicios de remisión (HCH, 23% 
contra PCC, 13%; P = 0,01).
Conclusión: Es necesario introducir medidas que mejoren la 
prestación de servicios en el entorno de la atención primaria, con el 
fin de garantizar la equidad a los usuarios de los servicios de salud.
